Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 5/20 | 0.69 |
| ▸ | NOS2 | P35228 | 5/20 | 0.69 |
| ▸ | NOS3 | P29474 | 4/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.44 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.42 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4056580 | 0.89 | NOS1 (0.58) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4061118 | 0.89 | SMN1; SMN2 (0.63) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4061756 | 0.87 | NOS3 (0.56) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4051806 | 0.87 | NOS3 (0.56) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4059606 | 0.87 | SMN1; SMN2 (0.71) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4053617 | 0.86 | NOS3 (0.57) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4055794 | 0.85 | NOS3 (0.60) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4053812 | 0.83 | NOS3 (0.54) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4049425 | 0.83 | HPGD (0.62) | NOS1NOS2NOS3SMN1; SMN2NPSR1 | |
| SCHEMBL4051158 | 0.83 | ALDH1A1 (0.57) | NOS1NOS2NOS3SMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622479-B2 | Bicyclic derivative, its production and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20050101647-A1 | Bicyclic derivative, its production and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-12 | — | — | US | disclosed |
| EP-1460067-A1 | BICYCLIC DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101647-A1 | Bicyclic derivative, its production and use | ABL1, SRC, PTK2B | NOS1 879/4885NOS2 1019/4885NOS3 907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.